Revenue | ₹1.35Cr |
Net Profits | ₹1.18Cr |
Net Profit Margins | 87.41% |
Biogen Pharmachem Industries Ltd’s revenue jumped 73.08% since last year same period to ₹1.35Cr in the Q4 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 486.96% jump in its revenue since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit jumped 59.46% since last year same period to ₹1.18Cr in the Q4 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 480.65% jump in its net profits since last 3-months.
Biogen Pharmachem Industries Ltd’s net profit margin fell -7.87% since last year same period to 87.41% in the Q4 2024-2025. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated 164.85% jumped in its net profit margins since last 3-months.
The revenue for Biogen Pharmachem Industries Ltd in the Q4 results 2024 was ₹1.35Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q4 results 2024 was ₹1.18Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q4 results 2024 was 87.41%.
The revenue for Biogen Pharmachem Industries Ltd in the Q4 results 2023 was ₹0.78Cr.
The net profit for Biogen Pharmachem Industries Ltd in the Q4 results 2023 was ₹0.74Cr.
The net profit margin for Biogen Pharmachem Industries Ltd in the Q4 results 2023 was 94.87%.